Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19
Authors:
- 28 August 2023
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 260, 115760
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (407779/2021-3)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 29 references indexed in Scilit:
- An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of CannabidiolFrontiers in Pharmacology, 2017
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesScientific Reports, 2017
- Early phytocannabinoid chemistry to endocannabinoids and beyondNature Reviews Neuroscience, 2014
- An efficient method for the transformation of naturally occurring monoterpenes into amines through rhodium-catalyzed hydroaminomethylationApplied Catalysis A: General, 2012
- A simple method for the alkaline hydrolysis of estersTetrahedron Letters, 2007
- Conversion of cannabidiol to Δ9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in miceForensic Toxicology, 2007
- New Cannabidiol Derivatives: Synthesis, Binding to Cannabinoid Receptor, and Evaluation of Their Antiinflammatory ActivityJournal of Medicinal Chemistry, 2006
- SARS–associated Coronavirus Replication in Cell LinesEmerging Infectious Diseases, 2006
- Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptorsOrganic & Biomolecular Chemistry, 2005
- Boron triflouride etherate on alimina - a modified Lewis acid reagent.Tetrahedron Letters, 1985